NEW YORK (GenomeWeb News) — Lumera yesterday said second-quarter revenues grew 40 percent as R&D spending fell 13 percent and net loss grew 3 percent.
 
Total receipts for the three months ended June 30 increased to $934,000 from $665,000 year over year.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.